CHINA PHARMA HOLDINGS, INC. — Investor Relations & Filings
Filings indexed
420
across all filing types
Latest filing
2026-05-15
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
CPHI
China Pharma Holdings, Inc. is a specialty pharmaceutical company that develops, manufactures, and markets a diversified portfolio of products. Through its subsidiary, Hainan Helpson Medicine & Biotechnique Co., Ltd., the company integrates drug research and development with production and sales. Its offerings include prescription drugs, over-the-counter (OTC) medications, and nutritional products. The company focuses on providing medical solutions to a broad market, serving more than 30 provinces and regions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| QUARTERLY REPORT | 2026-05-15 | English | |
| 8-K - CHINA PHARMA HOLDINGS, INC. (0001106644) (Filer) | 2026-03-03 | English | |
| 8-K Filing | 2026-02-10 | English | |
| 8-K Filing | 2026-01-06 | English | |
| FORM 8-K | 2025-12-23 | English | |
| CURRENT REPORT | 2025-12-10 | English |
Browse filings by year
27 years- 2026 4 filings
- 2025 9 filings
- 2024 24 filings
- 2023 22 filings
- 2022 14 filings
- 2021 17 filings
- 2020 8 filings
- 2019 7 filings
- 2018 8 filings
- 2017 9 filings
- 2016 9 filings
- 2015 12 filings
- 2014 7 filings
- 2013 12 filings
- 2012 20 filings
- 2011 30 filings
- 2010 24 filings
- 2009 42 filings
- 2008 23 filings
- 2007 16 filings
- 2006 19 filings
- 2005 31 filings
- 2004 14 filings
- 2003 16 filings
- 2002 9 filings
- 2001 8 filings
- 2000 6 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
4 filings
| |||||
| 46362645 | QUARTERLY REPORT | 2026-05-15 | English | ||
| 32887578 | 8-K - CHINA PHARMA HOLDINGS, INC. (0001106644) (Filer) | 2026-03-03 | English | ||
| 27409564 | 8-K Filing | 2026-02-10 | English | ||
| 27409556 | 8-K Filing | 2026-01-06 | English | ||
|
2025
9 filings
| |||||
| 11268771 | FORM 8-K | 2025-12-23 | English | ||
| 11268772 | CURRENT REPORT | 2025-12-10 | English | ||
| 11268774 | DEFINITIVE PROXY STATEMENT | 2025-11-14 | English | ||
| 11268777 | QUARTERLY REPORT | 2025-11-12 | English | ||
| 11268779 | PRELIMINARY PROXY STATEMENT | 2025-11-04 | English | ||
| 11268782 | QUARTERLY REPORT | 2025-08-14 | English | ||
| 11268789 | QUARTERLY REPORT | 2025-05-14 | English | ||
| 11268790 | CURRENT REPORT | 2025-04-04 | English | ||
| 11268794 | ANNUAL REPORT | 2025-03-31 | English | ||
|
2024
2 filings
| |||||
| 11268795 | CURRENT REPORT | 2024-12-26 | English | ||
| 11268796 | CURRENT REPORT | 2024-12-26 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
CHINA PHARMA HOLDINGS, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35359/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35359 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35359 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35359 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35359}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CHINA PHARMA HOLDINGS, INC. (id: 35359)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.